Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
WallStreetSelect 114
WallStreetSelect 114
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Nektar Therapeutics - Common Stock
(NQ:
NKTR
)
71.00
+4.65 (+7.01%)
Streaming Delayed Price
Updated: 4:00 PM EST, Feb 12, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
4,754,674
Open
63.33
Bid (Size)
70.00 (200)
Ask (Size)
70.60 (300)
Prev. Close
66.35
Today's Range
62.00 - 72.31
52wk Range
6.480 - 67.94
Shares Outstanding
183,801,441
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Nasdaq, S&P 500 Futures Rise, Markets Await Jobless Claims: Why NVDA, META, NKTR, NVCR, AMAT, ASTS Are On Traders' Radar Today
↗
Today 3:17 EST
Via
Stocktwits
Topics
Stocks
NKTR Stock Skyrockets: Wall Street Sees Up To 200% Upside As Skin Trial Crushes Even Bull-Case Forecasts
↗
February 11, 2026
The company reported that complete skin clearance rates increased twofold to fivefold during the maintenance phase of the trial.
Via
Stocktwits
Performance
YTD
+63.5%
+63.5%
1 Month
+83.1%
+83.1%
3 Month
+23.1%
+23.1%
6 Month
+176.0%
+176.0%
1 Year
+613.7%
+613.7%
More News
Read More
Top stock movements in today's session.
↗
February 10, 2026
Via
Chartmill
Here are the top movers in Tuesday's session.
↗
February 10, 2026
Via
Chartmill
These stocks are gapping in today's session
↗
February 10, 2026
Via
Chartmill
Earnings Scheduled For November 6, 2025
↗
November 06, 2025
Via
Benzinga
Top movers in Tuesday's pre-market session
↗
February 10, 2026
Via
Chartmill
NKTR Stock Soars After Nektar Reports Positive Atopic Dermatitis Trial Results
↗
February 10, 2026
Via
Stocktwits
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Nektar Therapeutics - NKTR
January 20, 2026
From
Pomerantz LLP
Via
GlobeNewswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Nektar Therapeutics - NKTR
January 13, 2026
From
Pomerantz LLP
Via
GlobeNewswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Nektar Therapeutics - NKTR
January 06, 2026
From
Pomerantz LLP
Via
GlobeNewswire
Ignore Nektar Therapeutics Stock in 2026 and Load Up on This One Instead
↗
January 05, 2026
Via
The Motley Fool
Topics
Bankruptcy
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Nektar Therapeutics - NKTR
December 30, 2025
From
Pomerantz LLP
Via
GlobeNewswire
This Biotech Is Up 194% in a Year but One Investor Took Millions Off the Table
↗
December 28, 2025
Via
The Motley Fool
Topics
Regulatory Compliance
ANI Stock Is Up 49% This Past Year, Revenue Is Surging, and One Fund Still Walked Away
↗
December 28, 2025
Via
The Motley Fool
Topics
Regulatory Compliance
Cidara Therapeutics Is Up Over 100%. Here's What Investors Need to Know.
↗
November 20, 2025
Via
The Motley Fool
Nektar Therapeutics (NASDAQ:NKTR) Q3 2025 Earnings Top Estimates, Sending Shares Higher
↗
November 06, 2025
Via
Chartmill
This Stock Is Up By 285% This Year But Could Still Jump By 53%, According to Wall Street
↗
October 13, 2025
Via
The Motley Fool
Here's Why Nektar Therapeutics Stock Rocketed 90.6% Higher in September
↗
October 05, 2025
Via
The Motley Fool
10 Health Care Stocks Whale Activity In Today's Session
↗
October 03, 2025
Via
Benzinga
These 2 Healthcare Stocks Are Up Over 100% in a Month. Can They Keep Climbing?
↗
September 21, 2025
Via
The Motley Fool
Why Nektar Therapeutics Stock Zoomed More Than 15% Higher Today
↗
September 18, 2025
Via
The Motley Fool
Why Is Nektar Therapeutics Stock Trading Lower On Thursday?
↗
September 18, 2025
Via
Benzinga
Why Nektar Therapeutics Rippled Higher This Week
↗
September 05, 2025
Via
The Motley Fool
Topics
Intellectual Property
What's Going On With Nektar Therapeutics Stock On Thursday?
↗
September 04, 2025
Via
Benzinga
Frequently Asked Questions
Is Nektar Therapeutics - Common Stock publicly traded?
Yes, Nektar Therapeutics - Common Stock is publicly traded.
What exchange does Nektar Therapeutics - Common Stock trade on?
Nektar Therapeutics - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Nektar Therapeutics - Common Stock?
The ticker symbol for Nektar Therapeutics - Common Stock is NKTR on the Nasdaq Stock Market
What is the current price of Nektar Therapeutics - Common Stock?
The current price of Nektar Therapeutics - Common Stock is 71.00
When was Nektar Therapeutics - Common Stock last traded?
The last trade of Nektar Therapeutics - Common Stock was at 02/12/26 04:00 PM ET
What is the market capitalization of Nektar Therapeutics - Common Stock?
The market capitalization of Nektar Therapeutics - Common Stock is 13.05B
How many shares of Nektar Therapeutics - Common Stock are outstanding?
Nektar Therapeutics - Common Stock has 13B shares outstanding.
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
